Koyfin Home > Directory > Health Care > Akebia Therapeutics > Price / Earnings (ntm)

Akebia Therapeutics Price / Earnings (ntm) Chart (AKBA)

Akebia Therapeutics annual/quarterly Price / Earnings (ntm) from 2016 to 2017. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
  • Akebia Therapeutics Price / Earnings (ntm) for the quarter ending March 03, 2017 was 18.72 a 2.05% increase of 0.38 year over year
  • Akebia Therapeutics Price / Earnings (ntm) for the last 12 months ending March 03, 2017 was 18.72 a 2.05% increase of 0.38 year over year
  • Akebia Therapeutics Annual Price / Earnings (ntm) for 2017 was 18.72 a 0.98% increase of 0.18 from 2016
  • Akebia Therapeutics Annual Price / Earnings (ntm) for 2017 was 18.54 a -0.69% decrease of -0.13 from 2016
  • Akebia Therapeutics Annual Price / Earnings (ntm) for 2017 was 18.66 a 1.76% increase of 0.33 from 2016
Other Valuation Metrics:
  • Akebia Therapeutics Market Cap for the quarter ending March 03, 2018 was $535m a -24.92% decrease of -133m year over year
  • Akebia Therapeutics Price / Book for the quarter ending March 03, 2018 was 3.80 a -378.76% decrease of -14.40 year over year
  • Akebia Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $217m a -91.84% decrease of -199m year over year
View Chart On Koyfin

Quarterly AKBA Price / Earnings (ntm) Data

03/201718.72
03/201718.54
03/201718.66
02/201718.33
02/201718.57
02/201718.19
02/201718.14
02/201718.28
02/201718.52
02/201719.00

Annual AKBA Price / Earnings (ntm) Data

201718.72
201718.54
201718.66
201718.33
201718.57
201718.19
201718.14
201718.28
201718.52
201719.00